Some of pharma’s biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The weight loss drug market could be worth $100 billion in the next few years. Naturally, other companies want in.
With Trump expected to chase increased oil exports and more drilling in the US, OPEC+’s fear of losing market share looms larger than ever.
Inflation is definitely looking like a “two-handle” problem. That’s investor-speak for a rate below 3% but above the Fed’s 2% target.
Don’t get too excited for cheaper Taylor Swift tickets: The rules just force sellers to present all the extra fees upfront.